Amylin Pharmaceuticals (AMLN) Earnings Preview For Upcoming Quarterly Earnings Release Date
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) is expected to report earnings for last fiscal quarter after the closing bell on February 06, 2012.
Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drug candidates for the treatment of diabetes, obesity, and other diseases. The company was founded in 1987 and is based in San Diego, California.
52 Week High: $16.58
52 Week Low: $8.03
Book Value: $2.14
Float Short:   7.46%
On average, analysts are expecting a drop of $-0.05 in earnings per share compared to last quarter's results of $-0.09. A beat of $-0.14 per share , will top the estimated mean earnings. Analyst estimates range between $-0.27 and $0.17 per share.
The stock has moved higher in price 25.31% in the last month, and changing from last year at this time -11.98%.
The stock has done very well as compared to the overall market. When comparing to the S&P 500, the year to date difference is 20.02%.
For the same fiscal period year-over-year, revenue has declined to $668.81 million for 2010 vs. $758.42 million for 2009. The bottom line has rising earnings year-over-year of $-152.31 million for 2010 vs. $-186.26 million for 2009.The company's earnings before interest and taxes are rising with an EBIT year-over-year of $-126.74 million for 2010 vs. $-173.35 million for 2009.
Here is a look at the fiscal year revenue. 
Here is the last few quarters to get an idea how well they perform compared to estimates 
Reported earnings per share compared to the mean estimate. Differences are rounded.
The total short interest number of shares for AMLN 
The number of days to cover short interest based on average daily trading volume for AMLN 
Thank you for reading my article. Please also feel free to share your thoughts and comments.
I use a proprietary blend of technical analysis, financial crowd behavior, and fundamentals in my short-term trades, and while not totally the same in longer swing trades to investments, the concepts used are similar. You may want to use this article as a starting point of your own research with your financial planner. I use Seeking Alpha, Edgar Online, and Yahoo Finance for most of my data. I use the confirmed symbols from earnings.com that I believe to be of the most interest.
